Autologous and Allogeneic Transplantation for Burkitt Lymphoma Outcomes and Changes in Utilization: A Report from the Center for International Blood and Marrow Transplant Research
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 01, 2013
- Source ID
- 10.1016/j.bbmt.2012.11.016
Entities
People
- Baldeep Wirk
- César O. Freytes
- David A. Rizzieri
- David G. Maloney
- David I. Marks
- David J. Inwards
- Gregory A. Hale
- Hillard M Lazarus
- Jack W. Hsu
- James L. Gajewski
- Jeanette Carreras
- Leena V. Maramattom
- Leona A. Holmberg
- Linda J. Burns
- Luciano J. Costa
- Mehdi Hamadani
- Michael Lill
- Mitchell S Cairo
- Parameswaran N. Hari
- Richard T. Maziarz
- Robert Peter Gale
- Silvia Montoto
- Thomas G. Gross
- Timothy S. Fenske
- William Arcese
Organizations
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- CellGenix (Germany)
- Children’s Leukemia Research Association
- Elevance Health, Inc.
- GSK
- Health Resources and Services Administration
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- StemCyte
- Swedish Orphan Biovitrum
- Tarix Orphan (United States)
- Terumo BCT (United States)